Impact of delayed blood donation sample processing and testing on SARS ‐ CoV ‐2 serological assay results in an evolving pandemic response
Transfusion · 2026
DOI: 10.1111/trf.70283 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transfusion, 2026. Verfasst von Marion C Lanteri und 15 weiteren Autor:innen. Beteiligte Einrichtung: Creative Testing Solutions, Tempe, Arizona, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antibodies, Viral, Blood Donors. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CDC HHS, Ortho Clinical Diagnostics, JG CDC HHS.
Abstract (Originalsprache)
Background
The two largest US blood collection organizations led a multiphased, multicenter nationwide SARS‐CoV‐2 blood donor‐based serosurveillance program. The potential impact of delayed sample processing and prolonged refrigerated or frozen storage on anti‐SARS‐CoV‐2 antibody detection was investigated.
Methods
Anti‐spike (S) IgG and anti‐nucleocapsid (N) total immunoglobulin levels were compared for 20 paired plasma/serum samples tested fresh and frozen after separation from cellular components on Day 5 or after ≤40 days of 4°C storage; 10 paired plasma/serum samples separated on Day 5 and tested immediately or after ≤67 days of 4°C storage; and 85 plasma and 950 serum samples tested fresh on Day 1 and after ≤209 days of −20°C storage post‐separation. Proportional Bland–Altman analyses were used to estimate average bias and 95% limits of agreement (LOA).
Results
Antibody reactivity was stable over time regardless of serum or plasma processing delays or prolonged refrigerated or frozen storage. Bland–Altman analyses suggest only minor deviations for anti‐S antibodies for samples separated within 5 days and tested frozen compared to fresh (bias: 4.23%, 95% LOA: −10.02; 18.47), after ≤40 days of storage at 4°C pre‐separation (9.51%, [−73.20; 92.22]) and after ≤67 days at 4°C post‐separation (−14.04%, [−28.12; 0.04]). Similar observations were obtained for anti‐N antibodies including samples retested after ≤209 days of storage at −20°C (−20.3%, [−81; 40.5]).
Conclusion
Despite challenges encountered in sample access and processing during a rapidly evolving pandemic, sample processing variability and testing delays minimally impacted serologic results and thus provide evidence for the validity of results in studies requiring variable sample handling conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Creative Testing Solutions, Tempe, Arizona, USA.
- University of California San Francisco, San Francisco, California, USA.
- Vitalant Research Institute, San Francisco, California, USA.
- American Red Cross, Rockville, Maryland, USA.
- Infectious Disease Consultant, North Potomac, Maryland, USA.
- National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia, USA.
ORCID-Profile: Marion C Lanteri, Jefferson M Jones, Eduard Grebe, Michael P Busch
Förderung
- CDC HHS
- Ortho Clinical Diagnostics
- JG CDC HHS
- Centers for Disease Control and Prevention
Zitieren
APA
Lanteri, M. C., Green, V., Sulaeman, H., Stone, M., Haynes, J., Di Germanio, C., Smith, S., Villaflor, P. G., Groves, J., Williamson, P. C., Stramer, S. L., Coughlin, M. M., Jones, J. M., Grebe, E., Busch, M. P., & Saa, P. (2026). Impact of delayed blood donation sample processing and testing on SARS ‐ CoV ‐2 serological assay results in an evolving pandemic response. Transfusion. https://doi.org/10.1111/trf.70283
Vancouver
Lanteri MC, Green V, Sulaeman H, Stone M, Haynes J, Di Germanio C, et al. Impact of delayed blood donation sample processing and testing on SARS ‐ CoV ‐2 serological assay results in an evolving pandemic response. Transfusion. 2026. doi:10.1111/trf.70283
BibTeX
@article{Lanteri2026,
author = {Lanteri, Marion C and Green, Valerie and Sulaeman, Hasan and Stone, Mars and Haynes, James and Di Germanio, Clara and Smith, Sakina and Villaflor, Patricia G and Groves, Jamel and Williamson, Phillip C and Stramer, Susan L and Coughlin, Melissa M and Jones, Jefferson M and Grebe, Eduard and Busch, Michael P and Saa, Paula},
title = {Impact of delayed blood donation sample processing and testing on SARS ‐ CoV ‐2 serological assay results in an evolving pandemic response},
journal = {Transfusion},
year = {2026},
doi = {10.1111/trf.70283}
}
EUVIMED